These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37619929)

  • 1. Sex differences in prevalence and prognosis of steatotic liver disease phenotypes: Biological sex matters.
    Ji H; Cheng S;
    J Hepatol; 2024 Feb; 80(2):e68-e69. PubMed ID: 37619929
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-cell profiling reveals distinct immune phenotypes that contribute to ischaemia-reperfusion injury after steatotic liver transplantation.
    Yang X; Lu D; Wang R; Lian Z; Lin Z; Zhuo J; Chen H; Yang M; Tan W; Yang M; Wei X; Wei Q; Zheng S; Xu X
    Cell Prolif; 2021 Oct; 54(10):e13116. PubMed ID: 34469018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the editor regarding "Exploring the landscape of steatotic liver disease in the general US population".
    Zou H; Xie Y
    Liver Int; 2023 Nov; 43(11):2576-2578. PubMed ID: 37665175
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat.
    Sun CK; Zhang XY; Zimmermann A; Davis G; Wheatley AM
    Transplantation; 2001 Nov; 72(10):1625-31. PubMed ID: 11726821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steatotic donor livers: Where is the risk-benefit maximized?
    Hamar M; Selzner M
    Liver Transpl; 2017 Oct; 23(S1):S34-S39. PubMed ID: 28734124
    [No Abstract]   [Full Text] [Related]  

  • 6. Loss of L-selectin-guided CD8
    Kolachala VL; Palle S; Shen M; Feng A; Shayakhmetov D; Gupta NA
    Hepatology; 2017 Oct; 66(4):1258-1274. PubMed ID: 28543181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and mortality prognosis of steatotic liver disease phenotypes.
    Sun Z; Zhou C; Zhang Y; Li P; Guo J; Lian Z; Ji H
    Ann Hepatol; 2024; 29(3):101487. PubMed ID: 38403067
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion.
    Evans ZP; Ellett JD; Schmidt MG; Schnellmann RG; Chavin KD
    J Biol Chem; 2008 Mar; 283(13):8573-9. PubMed ID: 18086675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent ischaemia maintains function after ischaemia reperfusion in steatotic livers.
    Steenks M; van Baal MC; Nieuwenhuijs VB; de Bruijn MT; Schiesser M; Teo MH; Callahan T; Padbury RT; Barritt GJ
    HPB (Oxford); 2010 May; 12(4):250-61. PubMed ID: 20590895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver.
    Kuroda S; Tashiro H; Igarashi Y; Tanimoto Y; Nambu J; Oshita A; Kobayashi T; Amano H; Tanaka Y; Ohdan H
    J Hepatol; 2012 Jan; 56(1):146-52. PubMed ID: 21756846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-nitroso-N-acetylcysteine ameliorates ischemia-reperfusion injury in the steatotic liver.
    Andraus W; Souza GF; Oliveira MG; Haddad LB; Coelho AM; Galvão FH; Leitão RM; D'Albuquerque LA; Machado MC
    Clinics (Sao Paulo); 2010 Jul; 65(7):715-21. PubMed ID: 20668630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin as additive of HTK preservation solution in cold ischemia/reperfusion injury of steatotic livers.
    Eipel C; Hübschmann U; Abshagen K; Wagner KF; Menger MD; Vollmar B
    J Surg Res; 2012 Mar; 173(1):171-9. PubMed ID: 21074785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes.
    Degli Esposti D; Sebagh M; Pham P; Reffas M; Poüs C; Brenner C; Azoulay D; Lemoine A
    Cell Death Dis; 2011 Jan; 2(1):e111. PubMed ID: 21368883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemia–reperfusion injury in patients with fatty liver and the clinical impact of steatotic liver on hepatic surgery.
    Tashiro H; Kuroda S; Mikuriya Y; Ohdan H
    Surg Today; 2014 Sep; 44(9):1611-25. PubMed ID: 24078000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic preconditioning attenuates ischemia/reperfusion injury in rat steatotic liver: role of heme oxygenase-1-mediated autophagy.
    Liu A; Guo E; Yang J; Li R; Yang Y; Liu S; Hu J; Jiang X; Dirsch O; Dahmen U; Sun J; Ouyang M
    Oncotarget; 2016 Nov; 7(48):78372-78386. PubMed ID: 27852058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia-reperfusion injury in steatotic liver transplantation.
    Yang M; Shu W; Zhai X; Yang X; Zhou H; Pan B; Li C; Lu D; Cai J; Zheng S; Jin B; Wei X; Xu X
    Cell Mol Life Sci; 2024 Feb; 81(1):83. PubMed ID: 38341383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activation.
    Ramachandran S; Liaw JM; Jia J; Glasgow SC; Liu W; Csontos K; Upadhya GA; Mohanakumar T; Chapman WC
    Transpl Immunol; 2012 Jun; 26(4):201-6. PubMed ID: 22286145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent Ischemic Preconditioning Protects Against Hepatic Ischemia-Reperfusion Injury and Extensive Hepatectomy in Steatotic Rat Liver.
    Sikalias N; Karatzas T; Alexiou K; Mountzalia L; Demonakou M; Kostakis ID; Zacharioudaki A; Papalois A; Kouraklis G
    J Invest Surg; 2018 Oct; 31(5):366-377. PubMed ID: 28644700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin protects steatotic and nonsteatotic liver grafts against cold ischemia and reperfusion injury.
    Zaoualí MA; Reiter RJ; Padrissa-Altés S; Boncompagni E; García JJ; Ben Abnennebi H; Freitas I; García-Gil FA; Rosello-Catafau J
    J Pineal Res; 2011 Mar; 50(2):213-21. PubMed ID: 21108657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic dysfunction-associated steatotic liver disease prevalence and risk factors in inflammatory bowel disease in tertiary center.
    Oliveira LDRP; Ribeiro TCDR; Mourao Junior CA; Barra MAL; Silva MHG; Shafee LP; Zacarias SM; Campos LDC; Valério HMG; Chebli JMF
    Rev Assoc Med Bras (1992); 2024; 70(6):e20231321. PubMed ID: 39045949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.